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ABSTRACT 
DELTAMETHRIN INDUCES ENDOPLASMIC RETICULUM STRESS AND 
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Deltamethrin is a widely used type-II pyrethroid insecticide in agricultural, 
industrial and domestic pest control. Previous studies have shown that deltamethrin can 
induce ER stress response in vivo. However, it is still unclear whether deltamethrin can 
disturb protein homeostasis. To investigate how deltamethrin affects ER protein 
homeostasis, we used a C. elegans model of protein misfolding. In the current study, 
deltamethrin induced ER stress response in C. elegans. Moreover, exposure to 
deltamethrin increased the accumulation of unfolded and misfolded proteins in a C. 
elegans model of polyglutamine aggregation in body wall muscles. Deltamethrin also 
increased the toxicity of polyglutamine aggregates in C. elegans, as characterized by 
decreased locomotion with deltamethrin treatment. These data indicate that exposure to 
deltamethrin can induce ER stress response, increase the accumulation and proteotoxicity 
of unfolded and misfolded proteins. As ER stress plays a pathological role in many 
diseases, these findings provide evidence for the potential pathological role of 
deltamethrin in ER stress-related diseases.  
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Disturbances to the regular function of the endoplasmic reticulum (ER) can lead to the 
accumulation of unfolded and misfolded proteins in the ER, a condition called ER stress 
(1, 2). ER stress has been associated with the pathology of many conditions, including 
aging, neurodegeneration, obesity, and diabetes (2, 3). Moreover, increasing evidence has 
pointed out that environmental contaminants, like pyrethroid insecticides, can contribute 
to diseases associated with ER stress (4, 5). Thus, identification of potential ER stress-
inducing environmental contaminants may help in the prevention and treatment of 
diseases associated with ER stress. 
 Deltamethrin is a type II pyrethroid that is widely used as an insecticide in 
agriculture, industrial, medical and home pest control (6, 7). Pyrethroids are considered 
as low-toxicity replacements to organophosphorus and carbamate insecticides (6). 
However, recent studies have indicated that a high level of exposure to deltamethrin can 
result in convulsion, tremor, and ataxia in rodents (8-10). In addition, deltamethrin has 
been found to induce ER stress response in vitro and in vivo (4, 11). Growing evidence 
suggests that deltamethrin can induce ER stress and disturb protein homeostasis (4, 10, 
11). Therefore, we investigate the role of deltamethrin in ER stress and protein 
misfolding in vivo for the first time. 
 Caenorhabditis elegans, a free-living nematode, was used in this study as a model 
organism to investigate the role of deltamethrin in ER stress, protein misfolding, and 
proteotoxicity. C. elegans model has many advantages over rodent models, including 
short lifespan, fully sequenced genome, and ease of maintenance (12). Additionally, this 
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nematode model has been established and used extensively for studies on ER stress and 








Caenorhabditis elegans is a widely used animal model that has many advantages over 
other in vivo models (12). The wildtype C. elegans has a short life cycle (about 2 days at 
25°C), a relatively short lifespan (about 2-3 weeks), and a large brood size (more than 
300 progeny) (12). In addition, experiments using C. elegans, which has a transparent 
body, only require relatively simple laboratory conditions and do not need institutional 
committee approval (12). For example, C. elegans is fed with non-pathogenic 
Escherichia coli OP50 and raised on petri dishes or in liquid media (12). Thus, research 
using C. elegans is much more time and cost-efficient than research using vertebrate 
models. Moreover, C. elegans shares the basic biology of vertebrates; 83% of its 
proteome is homologous to that of humans, and about two thirds of its genes are related 
to human diseases (14). In addition, C. elegans has a completely sequenced genome and 
more than 3,000 mutants are available, and RNA interference (RNAi), microinjection, as 
well as genetic crosses, are amenable in this worm model (14). These reasons make this 
animal model a powerful toolbox in many life science research areas (15). 
2.2 Basic biology of C. elegans 
C. elegans is a free-living nematode about 1-1.5 mm long in its adult stage (14). It has a 
life cycle of about 2 days; this includes an embryonic stage, four larval stages (L1-L4), 
and the adult stage (12). Its eggs have an impermeable shell that isolates them from the 
outside environment (12). Hatched eggs turn into L1-stage worms, which proceed with 
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adequate food into the L2-L4 stages in the developmental process. The cuticle of the 
worms is reestablished after each larval stage (12). When the nematode encounters harsh 
environments, including an absence of food and the presence of unfavorable chemicals, it 
arrests development and enters a dormant state named a dauer larvae stage (16, 17). 
Nematodes in the dauer stage will continue to grow into L4 stage worms with sufficient 
food and favorable environmental conditions (16). 
C. elegans has a high degree of cell differentiation and specialization (16). The 
worm has five systems; the epidermis, and muscular, digestive, nervous, and reproductive 
systems (16). The presence of well-defined tissues and organs makes the worm useful for 
research in biological processes involved in multicellular organisms (18). 
The epidermis of the worm is composed of epidermal cells that secrete the cuticle, 
an exoskeleton that helps in the locomotion, protection, and growth of the worm (12). 
The cuticle of C. elegans, which consists of collagens, proteins, glycoproteins, and lipids, 
is reestablished five times during its development (12). Movement is controlled by 
muscles that are attached to the epidermis (16). The relaxation and contraction of these 
muscles are necessary for the sinusoidal movement of the animal (16). For example, one 
of the unc (uncoordinated) genes, unc-54, encodes proteins that are needed for the typical 
sinusoidal movement of the worms, and alterations to unc-54 can cause a paralytic 
phenotype (16). 
The digestive system of C. elegans is primarily composed of the pharynx, 
intestine, rectum, and anus (16). When the worm eats, food passes through the mouth 
opening first and then gets grinded at the pharynx (16). Next, the ground food reaches the 
intestine, where it is further digested, and where nutrients are absorbed, utilized, or stored 
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(12). After the food has been digested in the intestine, remaining waste passes the rectum 
and anus and gets excreted through a rectal valve; the defecation cycle is about 50 
seconds (12). 
The nervous system of C. elegans contains 302 neurons for an adult 
hermaphrodite (12). C. elegans has three classes of neurons; chemosensory, 
mechanosensory, and thermosensory neurons (19). The worm model shares many 
proteins with mammalian neurons involved in the formation, trafficking, and releasing of 
synaptic vesicles (19). Because C. elegans uses many of the same neurotrasmitters as 
vertebrates - including dopamine, serotonin, gamma-amino butyric acid, and 
acetylcholine - it has been used as a model for many neurodegenerative diseases (16). 
The reproductive tissue of the adult hermaphrodite C. elegans is comprised of the 
somatic gonad that houses the germline and egg-laying apparatuses (12).  Over 99% of 
the worms are self-fertilizing hermaphrodites, which helps to preserve homozygous 
clones (16).  
2.3 ER Stress  
Proteins are synthesized by the ribosomes attached to the rough ER. They are modified 
and folded by chaperones and enzymes in the ER, and then transported out of the ER-
lumen (20). As the ER is a highly dynamic organelle, many parameters in the ER 
microenvironment can affect the elements of protein folding, including chaperones, 
foldases, calcium levels, the redox milieu, the phospholipid composition of the ER 
membrane, etc. (20). Once protein folding is disturbed or inadequate, unfolded and 
misfolded proteins can accumulate in the ER lumen and the cytoplasm, a condition 
named ER stress (1, 2). The ER has a ‘quality control’ system to degrade unfolded and 
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misfolded proteins: the ER-associated degradation (ERAD) pathway delivers damaged 
protein to the proteasome, and the autophagy pathway transports unfolded and misfolded 
proteins to the lysosome (21). However, overaccumulation of unfolded and misfolded 
proteins leads to activation of the unfolded protein response (UPRER), which has both 
protective and apoptotic components (22). It has been reported that the UPRER has a 
pathological role in many conditions, including aging, neurodegenerative diseases, 
obesity, and type 2 diabetes (2). Thus, understanding the role of UPRER may provide 
important insights into the pathology and new treatment of these and other diseases. 
2.4 Unfolded protein response in ER (UPRER) 
The UPRER is a signaling pathway that is conserved from yeasts to mammals, which 
allows researchers to study this pathway in a variety of models, including C. elegans 
(23). The UPRER stress response system can monitor the accumulation of unfolded and 
misfolded proteins and correct protein folding and processing (20). The UPRER system 
tries to maintain normal cell function by reducing protein-folding workload, 
strengthening protein-folding capacity, as well as removing and degrading unfolded and 
misfolded proteins (23). However, when ER stress cannot properly handle unfolded and 
misfolded proteins, the apoptotic pathway can be triggered by the UPRER via UPRER 
signaling pathways (20).  
2.5 The UPRER Signaling Pathways 
The UPRER system includes three branches, each represents by one of three 
transmembrane proteins: the inositol-requiring kinase-1 (IRE-1), protein kinase RNA-like 
endoplasmic reticulum kinase (PERK), and activating transcription factor-6 (ATF-6) 
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(23). All these branches have a luminal domain that can sense the amount of unfolded 
and misfolded proteins and initiate responses to manage ER stress (21).  
2.5.1 IRE-1 Pathway 
The IRE-1 branch of the UPRER is conserved from yeasts to humans (5). Although the 
exact mechanism of IRE-1 activation is not completely understood, one study suggests 
that unfolded and misfolded proteins, as well as binding immunoglobulin protein (BiP), 
participate in modulation of IRE-1 (24). Without unfolded or misfolded proteins, BiP 
binds to IRE-1 to inhibit its activity (25). In the presence of unfolded and misfolded 
proteins, BiP binds to them and activates IRE-1 (25). Activation of IRE-1 results in the 
dimerization and autophosphorylation of the protein (26). The activated IRE-1 acts as an 
endoribonuclease that cleaves a 26-base fragment from X-box binding protein-1 (XBP-1) 
mRNA, and the spliced mRNA is translated into spliced X-box binding protein-1 (spliced 
XBP-1) (26). In mammals, spliced XBP-1s regulate components in protein degradation, 
protein folding, and ER membrane biogenesis, and this regulation can alleviate ER stress 
as well as increase ER capacity (26). In C. elegans, spliced XBP-1s can upregulate heat 
shock protein 4 (HSP-4, the homolog of mammalian BiP), as well as ER-associated 
Degradation (ERAD) components and other chaperones (27-31). 
2.5.2 PERK Pathway 
PERK is an ER-resident transmembrane protein (32). PERK is activated by dissociation 
of BiP from its luminal domain (25). The activated PERK can phosphorylate eukaryotic 
translational initiation factor 2α (eIF2α) and downregulate global protein synthesis to 
alleviate ER workload (32). Moreover, the activation of eIF2α can also increase the 
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translation of protective proteins, including activating transcription factor 4 (ATF4) (33). 
In mammals, ATF4 controls a range of target genes, including the pro-apoptotic 
transcription factor, C/EBP homologous protein (CHOP) (34-36). The downstream 
targets of ATF4 in C. elegans are, however, still not known. 
2.5.3 ATF6 Pathway 
ATF-6 is a transmembrane transcription factor that is activated upon accumulation of 
unfolded and misfolded proteins (34). Once activated, ATF-6 translocates to the Golgi 
apparatus, where it is cleaved by site-1 protease (S1P) and site-2 protease (S2P) to 
generate the cleaved form of ATF-6 (5). Once cleaved, ATF-6 upregulates a wide range 
of UPRER target genes, including chaperones, protein foldases, and components in the 
protein degradation ERAD pathway in mammals (5). However, in C. elegans, ATF-6 
regulates fewer target genes than in mammals, and the specific role of ATF-6 branch in 
C. elegans is still to be determined (37). 
2.6 Conditions related to ER Stress and the UPRER 
2.6.1 Aging and Reduced UPRER 
The ability of UPRER to respond to ER stress declines with age. This may allow for an 
accumulation of unfolded and misfolded proteins and contribute to age-related diseases 
(35). In addition, the UPRER response to protein chaperones and foldases also decreases 
with aging (38). Many of these chaperones suffer oxidative damage during aging, which 
can further imperil the function of the UPRER system (39). The decline in the protective 
role of the UPRER during aging is accompanied by an increase of pro-apoptotic markers 
in the UPRER (38). Expression of pro-apoptotic markers, including C/EBP homologous 
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protein (CHOP) and caspase-12, are upregulated in the aged, but not young rats, when 
treated with lactacystin, a proteasome inhibitor that disrupts protein homeostasis (40). 
Thus, overall, aging reduces the protective functions of the UPRER and strengthens its 
pro-apoptotic signaling, which further leads to age-related accumulation of unfolded and 
misfolded protein and cell dysfunction. 
The homolog of insulin/insulin-like growth factor receptor (IIS), DAF-2, is well 
known to be associated with lifespan in C. elegans (41). The DAF-2 mutant has an 
extended lifespan that depends on the activation of the forkhead box transcription factor 
(FOXO). In addition, UPRER components ire-1 and xbp-1 are involved in lifespan 
extension, which occurs as xbp-1 upregulates daf-16 in the DAF-2 mutant (42).  
In addition to IIS, protein skinhead-1 (skn-1), the mammalian homolog of nuclear 
respiratory factor 2 (Nrf2), has been associated with longevity in C. elegans (43). A 
recent report indicates that Vitamin D can extend lifespan through activation of skn-1 in 
C. elegans, and the activation of skn-1 requires UPRER components ire-1 and xbp-1 (44). 
Consistently, others have reported that skn-1 contributes to longevity by activating the 
IRE-1 and PERK branches of the UPRER (33). 
Improving ER protein homeostasis also contributes to longevity in C. elegans 
(35). As UPRER regulates many components that can improve ER protein homeostasis 
(41), upregulation of UPRER can improve age-related diseases (45). In fact, the activation 
of the hexosamine pathway, which has been linked to UPRER upregulation, can improve 
longevity and reduce protein aggregation by enhancing ER-associated protein 
degradation, proteasome function, and autophagy in C. elegans (45, 46).  
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2.6.2 Neurodegenerative disease 
A common pathological marker for many neurodegenerative disorders is the 
accumulation of unfolded and misfolded proteins in neurons (47). Thus, studying 
stressors and potential therapies that target unfolded and misfolded proteins may provide 
a better understanding of these disorders and play a crucial role in the development of 
preventive and treatment strategies for these neurodegenerative disorders (47).  
2.6.2.1 Alzheimer’s Disease 
Alzheimer’s is a neurodegenerative disease exhibiting the presence of extracellular senile 
plaques and intracellular neurofibrillary tangles (17). The major component of senile 
plaques is β-amyloid (Aβ), while the neurofibrillary tangles are formed by aggregation of 
tau proteins (17). Many studies have reported that ER stress and the UPRER system are 
involved in the development of Alzheimer’s disease (48, 49). Recent studies have shown 
that Aβ can accumulate at the ER lumen and increase free and bound Ca2+ in neurons 
(50). This causes ER stress and activation of the UPRER (50), which leads to impaired 
synaptic function and eventually induces apoptosis of neurons (49). In addition, a protein 
associated with Alzheimer’s disease, mutated presenilin-1, can increase Ca2+ release in 
the ER and inhibit IRE-1 activity, which worsen ER homeostasis and reduce UPRER 
signaling (51).  
In humans, Aβ is produced when amyloid precursor protein (APP) is cleaved by 
β- and γ-secretase (17). However, the C. elegans homolog of APP, apl-1, does not 
contain the genetic information for β-amyloid (17). Thus, researchers have created C. 
elegans models of Alzheimer’s disease by introducing human Aβ1-42 to generate 
transgenic strains (52). They have applied these models to screen bioactive compounds 
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and discover contributors to the disease (52). Using this model, resveratrol is reported to 
reduce the toxicity of Aβ aggregation through upregulation of autophagy and proteasomal 
degradation (52). Ablation of the IRE-1 branch of the UPRER may reduce the toxicity of 
β-amyloid, although the role of IRE-1 in Alzheimer’s disease has been controversial (53, 
54). 
2.6.2.2 Parkinson’s Disease 
Parkinson’s disease is a neurodegenerative disorder marked clinically by tremors, 
bradykinesia, and impaired balance (14). These have been associated with two main 
pathological hallmarks: the formation of proteinaceous inclusions (Lewy Bodies) and the 
loss of dopaminergic neurons from the substantia nigra (14). Recent studies have 
identified a pathological role for ER stress in Parkinson’s disease (55). Aggregation of α-
synuclein in the ER can impact ER homeostasis, including depletion of ER chaperones 
and inhibition of ER-to-Golgi trafficking (56-58). Although it is generally agreed that ER 
stress is involved in the neuropathology of Parkinson’s Disease, the exact mechanism for 
how induction of ER stress causes the loss of dopaminergic neurons in Parkinson’s 
disease is not yet well understood (58).  
In humans, α-synuclein aggregates are products of the α-syn gene (14). Because 
C. elegans does not possess this gene (14), C. elegans’ models of α-synuclein are 
established with human α-synuclein expression in neurons or muscle promoters (19). In 
addition, neurotoxins like 6-hydroxydopamine can be used to degenerate dopaminergic 
neurons in C. elegans, which also induces ER stress (59). Consistently, mutation of 
leucine-rich repeat kinase 2 (LRRK2), a gene commonly associated with Parkinson’s 
disease, has been shown to inhibit UPRER responses, leading to increased ER stress in C. 
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elegans (59). Moreover, a type of bacterial metabolite, phenazine derivatives, has been 
shown to exacerbate ER stress in the worm model of Parkinson’s disease (13).  
2.6.2.3 Huntington’s Disease 
Huntington’s disease is an inherited neurodegenerative disease that results in cognitive, 
motor, and psychiatric changes (60). This disease results from expansion of CAG repeats 
in the Huntingtin gene that adds a long polyglutamine repeat to the Huntingtin protein 
(60). Recent studies have linked ER stress to the development of Huntington’s Disease in 
several ways: [1] polyglutamine fragments can entrap ERAD proteins (Npl4, Ufd1, and 
p97) and induce ER stress (61), [2] overexpression of these ERAD proteins can reduce 
the toxicity caused by polyglutamine (61), and [3] polyglutamine indirectly increases 
accumulation of unfolded and misfolded proteins by disruption of vesicular trafficking 
and by causing defects in lysosome-mediated protein degradation (62). 
In C. elegans, the human huntingtin-polyglutamine protein is incorporated in 
muscle or neurons to generate disease models for relatively easy detection of disease 
development (18, 63). Using these models, UPRER components and changes in the 
disease progression can be investigated. For example, manganese treatment can induce 
ER stress and increase polyglutamine aggregates as an indicator of Huntington’s disease 
(64). This provides further evidence that ER stress is associated with the development of 
Huntington’s disease (64). 
2.6.2.4 Obesity and Type 2 Diabetes 
Obesity is also known to be associated with increased ER stress and activated UPRER in 
many tissues, such as hypothalamus, liver, muscle, and adipose tissue (65). Treatment of 
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chemical chaperones, which improve protein folding and synthesis, can improve ER 
function and reduce ER stress markers in the liver and adipose tissue of obese mice (66). 
This indicates that obesity-associated ER stress may result from a high protein synthesis 
load (66). In addition, increased free fatty acid load, as well as changes in the 
composition of the ER membrane, can also activate the UPRER, which suggests that the 
UPRER responds to lipid imbalances (67-70).  
The activated UPRER plays a significant role in the development of obesity-related 
disorders, particularly type 2 diabetes (65). Increased ER stress in obesity can lead to the 
induction of c-Jun N-terminal kinases (JNK), and thus reduce the activity of insulin 
receptor substrate-1 (IRS1) to down-regulate insulin signaling (66). The UPRER also 
interacts with hepatic gluconeogenesis by ATF-6, one of the three branches of the 
UPRER, to inhibit the activity of CREB-regulated transcription coactivator 2 (CRTC2), 
which results in down-regulation of gluconeogenesis in the liver (71). With increased 
insulin demand due to insulin resistance, the pancreatic β-cells can exceed their protein 
folding capacity and generate ER stress (5). Eventually, prolonged ER stress in the 
pancreas can trigger the UPR-mediated apoptosis in β-cells, exacerbate hyperglycemia, 
and eventually increase insulin deficiency (22). 
C. elegans is an established model for research in obesity and type 2 diabetes. The 
key pathways on energy metabolism, such as the lipid metabolism and insulin/insulin-like 
growth factor signaling (IIS), are conserved between mammals and C. elegans (72). For 
example, researchers have found that a change of phospholipid composition in the ER 
membrane in C. elegans can activate UPRER without disturbing ER proteostasis (68). 
This indicates that in C. elegans lipid imbalance may directly activate the UPRER (68), 
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which is consistent with observations in mammals (73). Thus, the worm model has 
tremendous potential for valuable research in obesity and diabetes, particularly research 
in ER stress- and UPR- mediated mechanisms. 
2.7 Conclusion 
The introduction of the C. elegans model of human diseases has provided a versatile and 
powerful platform for studying the pathology and potential treatments of these diseases. 
As one of the complex pathways in cells, UPRER is involved in the pathology of many 
diseases. Using the worm model to study the UPRER already has been proven to be 
fruitful, and continued discoveries using this worm model will provide important insights 





MATERIALS AND METHODS 
3.1 Materials 
 All the C. elegans strains and Escherichia coli OP50 used in the current study 
were obtained from Caenorhabditis Genetics Center (CGC), University of Minnesota. 
Strains used include SJ4005 [zcIs4 (phsp-4::GFP)]; AM141[rmIs133 (unc-
54p::Q40::YFP)]. All the chemicals were purchased from Thermo Fisher Scientific 
(Pittsburgh, PA, USA) unless otherwise indicated. Household Clorox bleach (The Clorox 
Company, Oakland, CA, USA) was used for synchronizing the worms. 
Fluorodeoxyuridine (FUdR) and carbenicilin were purchased from Sigma-Aldrich Co. 
(St. Louis, MO, USA).  
3.2 C. elegans Culture 
C. elegans were cultured using standard methods as previously described (74). 
Nematode growth medium (NGM), M9-buffer solution, and S-complete solution were 
prepared as the previous protocols (74). Briefly, after a synchronous worm population 
was acquired, synchronized L1 worms were cultured in 12-wells plates at 25°C with 
treatments (25 µM deltamethrin or 0.1% DMSO as control).  
3.3 Fluorescence Microscopy 
Worms were immobilized in 2 mM levamisole and mounted on a slide with 3% 
agarose using a cover slip before imaging. After preparation of the slides, fluorescent 
images were taken using a Nikon Eclipse Ti-U Inverted Microscope (Micro Video 
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Instruments, Avon, MA). The average GFP intensity of SJ4005 worms was measured for 
ER stress response, and the average number and size of polyglutamine YFP inclusions 
were scored for AM141 worms. For each treatment, about 30 worms were used. Analysis 
of the images was performed using the ImageJ software developed by the National 
Institute of Health (NIH). 
3.4 Growth Rate Assay 
After 48 hours of treatment, worms were transferred from liquid media to NGM 
plates, and the worms at each developmental stage were counted for growth rate analysis.  
3.5 Locomotion Assay 
Locomotion activity of the worms was measured using the Wormlab tracking 
system (MBF Bioscience, Williston, VT, USA) as previously described (75, 76). Low-
peptone nematode growth media (NGM) plates were prepared and used for tracking as 
previously reported (75). Worms from each treatment groups were transferred from liquid 
media to NGM plates and stabilized for about 15 minutes. After stabilization, a 1-minute 
video was captured at 7.99 frames per second. Videos were analyzed using the Wormlab 
software, and the Wormlab software generated data for worm size and locomotive 
behavior. 
3.6 Statistical Analysis 
 Data values are given as means ± S.E. and analyzed using statistical software 
GraphPad Prism v.7.0 (GraphPad Software, La Jolla, CA, USA). Differences among 
groups were analyzed using one-way or two-way analysis of variance (ANOVA) and 
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4.1 Deltamethrin induces ER stress response in C. elegans 
The induction of ER stress response in worms can be measured by using the SJ4005 
strain with an hsp-4p::GFP reporter. Hsp-4 is the homolog of mammalian ER chaperone 
BiP, and BiP is used as a general marker of ER stress response (5). During ER stress, hsp-
4 is upregulated and the GFP intensity in SJ4005 worms is higher than without ER stress 
(68). The expression of the hsp-4 GFP reporter was measured to investigate whether 
deltamethrin can induce ER stress response in C. elegans. In this experimental, a 4-hour 
treatment of 3 mM dithiothreitol (DTT), an ER stress inducer, was used as positive 
control. As shown in Figure 4.1, 25 µM deltamethrin increased the ER stress response 
significantly by 44% compared to control. Since the induction of  ER stress is associated 
with the accumulation of unfolded and misfolded proteins, the effect of deltamethrin on 
protein misfolding was examined using a C. elegans polyglutamine model (64). 
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Figure 4.1 Effects of deltamethrin on ER stress response. (A) Representative images of 
SJ4005 worms on day 3 with control, deltamethrin and dithiothreitol (DTT) treatments. 
(B) Deltamethrin induced ER stress response in C. elegans. Treatment of deltamethrin 
started from L1 stage for three days. The data are described as means ± S.E. (control 
n=29, deltamethrin n=36, DTT n=69). Means with different letters are significantly 
different (P<0.05). 
4.2 Effect of deltamethrin on locomotive activity, growth rate and worm size 
Exposure to deltamethrin has been linked to the reduction of locomotive activities in C. 
elegans (77) and improper development in zebrafish and Daphnia (4, 78). However, 
treatment of deltamethrin at 25 µM had no significant effects on the size (Figure 
4.2A&B), and locomotive activities (Figure 4.2C&D) or growth rate of C. elegans strain 
SJ4005 (Figure 4.2E). 
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Figure 4.2 Effects of deltamethrin on the size, growth rate, and locomotive activity of 
SJ4005 worm. (A) Average body length of worms on day 4 of treatment. (B) Average 
body width of worms on day 4 of treatment. (C) Average moving speed on day 4 of 
treatment. (D) Mean amplitude of sinusoidal movement on day 4 of treatment. (E) 
Proportion of worms of each growth stage after 2 days of treatment. All worms were 
treated with deltamethrin from L1 stage. And the data were presented as mean means ± 
S.E. (n=184-191 for size and locomotion assay; n=3 plates and about 100 worms per 
plate for growth rate assay). Means with different letters are significantly different 
(P<0.05). 
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4.3 Deltamethrin increased polyglutamine aggregation in C. elegans 
The effect of deltamethrin on the aggregation of polyglutamine is tested using the C. 
elegans transgenic strain AM141 expressing Q40::YFP in its body wall muscle cells (64). 
Expression of polyglutamine stretch leads to the formation of aggregation that can be 
visualized by fluorescent microscopy (79). Our results showed that treatment with 25 µM 
of deltamethrin had no significant effect on the average number of polyglutamine 
aggregates (Figure 4.3A), but significant changes in the average size of polyglutamine 
aggregates occurred (Figure 4.3B). According to previous studies, increased 
polyglutamine aggregation may result in polyglutamine-mediated motility defects (79).  




































































Figure 4.3 Effects of deltamethrin on the number and size of polyglutamine aggregation 
in C. elegans. (A) The number of polyglutamine aggregation was counted from YFP 
images using ImageJ. (B) The average size of polyglutamine aggregation was counted 
from YFP images using ImageJ. (C) Representative images of AM141 worms treated 
with 0.1% DMSO in control group. (D) Representative images of AM141 worms treated 
with 25 µM deltamethrin. Treatment of deltamethrin starts from L1 stage and lasts for six 
days. The data are described as means ± S.E. (control n=33, deltamethrin n=37). Means 
with different letters are significantly different (P<0.05). 
4.4 Deltamethrin increased the proteotoxicity of polyglutamine in C. elegans 
Prior studies have shown that polyglutamine aggregates can induce proteotoxicity in 
muscle cells of C. elegans by disrupting the actin and myosin myofibrillar networks (79). 
As a result of the polyglutamine-mediated proteotoxicity, the worms show a reduction in 
locomiton (79). In the current study, the locomotive activity was measured using 
WormLab system on day 4 with or without deltamethrin to investigate whether 
deltamethrin would exacerbate the proteotoxicity of polyglutamine. Average moving 
speed means the average distance the worm moves during a specified time period, and 
amplitude refers to the distance of vertical movement over the sinusoidal track of C. 
elegans (75). As for body size, treatment of 25 μM deltamethrin resulted in a significant 
reduction in body length by 7% (Figure 4.4A), but result in no significant changes in 
body width (Figure 4.4B). In terms of locomotive activities, deltamethrin treated worms 
had a significant reduction in average moving speed (~31%) (Figure 4.4C) and a 
significant reduction in mean amplitude (~11%) (Figure 4.4D). Furthermore, the growth 
rate (Figure 4.4E) of worms was not significantly different between control and 
deltamethrin-treated groups. Overall, these results indicate that deltamethrin treatment 
exacerbates the proteotoxicity of polyglutamine aggregation. 
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Figure 4.4 Effects of deltamethrin on the size, growth rate, and locomotive activity of 
AM141 worm. (A) Average body length of worms on day 4 of treatment. (B) Average 
body width of worms on day 4 of treatment. (C) Average moving speed on day 4 of 
treatment. (D) Mean amplitude of sinusoidal movement on day 4 of treatment. (E) 
Proportion of worms of each growth stage after 2 days of treatment. All worms were 
treated with deltamethrin from L1 stage. The data were presented as mean means ± S.E. 
(n=187-194 for size and locomotion assay; n=3 plates and about 100 worms per plate for 





Previously, others have reported that deltamethrin induces ER stress response/ unfolded 
protein response (UPRER) in nerve cells and mice (4, 11). In the current study, 
deltamethrin treatment induced ER stress response in C. elegans, and is the first report 
that deltamethrin increased protein misfolding and exacerbated proteotoxicity in vivo 
using C. elegans. 
ER is the organelle that synthesizes, folds and processs proteins and ER stress is 
defined as a condition where unfolded and misfolded proteins accumulate in the ER 
lumen and activate the ER stress response/UPRER (5, 68). Disruption of the protein 
folding and processing in ER can lead to accumulation of unfolded and misfolded 
proteins in the ER and trigger a specific stress response named the UPRER (5). 
Accumulation of unfolded and misfolded proteins plays a pathological role in many 
conditions, including aging, obesity, diabetes, and neurodegeneration diseases (2, 13, 65). 
For example, under ER stress, overaccumulated unfolded and misfolded proteins can 
form inclusions in neuron cells, and many of these inclusions (e.g. α-synuclein and β-
amyloid) have been proven to be neurotoxic (2, 58). Previous reports have indicated that 
deltamethrin can induce ER stress response/UPRER (4, 11). However, induction of ER 
stress response/UPRER alone may not directly indicate accumulation of unfolded and 
misfolded proteins, because UPRER can be activated by other conditions without 
accumulation of unfolded and misfolded proteins, such as change of ER membrane 
phospholipid composition, oxidative stress, and metabolic stress (5, 33, 68). In the 
current study, we confirmed that deltamethrin caused protein misfolding and 
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proteotoxicity along with induction of ER stress response/UPRER in C. elegans by using a 
protein misfolding model based on polyglutamine aggregation.  
In the current study, deltamethrin increased polyglutamine aggregation and 
resulted in proteotoxicity, as determined by reduced average moving speed and amplitude 
(80). Increased polyglutamine aggregation seen in the presence of deltamethrin may have 
occurred due to a slowing or disruption of the removal of unfolded and misfolded 
proteins in the lysosome-mediated protein degradation process (62, 79). A previous study 
implied that deltamethrin activated the UPRER and impaired the hippocampal function 
possibly by UPRER-mediated apoptosis (4). Others suggested that deltamethrin activated 
general ER stress response and induced apoptosis through activation of the PERK branch 
of the UPRER in SK-N-AS neuroblastoma cells (11). Another pyrethroid insecticide, 
cypermethrin, impaired proteostasis by alterations to protein synthesis, maturation, and 
degradation genes in the brain of mice (81). Our results are consistent with these reports 
that deltamethrin may induce ER stress and protein misfolding. The alteration of calcium 
homeostasis and oxidative stress associated with deltamethrin, however, may also 
contribute to its effects on ER stress (77, 82). Thus, it is still not clear how deltamethrin 
increased polyglutamine aggregation and proteotoxicity.  
Our results also showed that the worm length of AM141 worms was slightly, but 
significantly, reduced (7%) by deltamethrin and may indicate that deltamethrin had 
affected the development of C. elegans. Interestingly, deltamethrin did not influence the 
growth rate of AM141 worms, nor did it reduce the worm length in SJ4005 worms. These 
results are consistent with a previous report that deltamethrin has little to minimal impact 
on the growth rate of C. elegans (6). It has been previous shown that extreme ER stress 
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can lead to developmental arrest and larvae lethality in C. elegans, whereas moderate 
level of ER stress has no significant effect on the development of worms (68, 83). Based 
on the above evidence, it appears that deltamethrin treatment at 25 μM had a moderate 
effect on ER stress but had limited influence on the development of C. elegans.  
Pyrethroids have been reported to affect locomotive activity in many animal 
models as it targets neurons (84). Nonetheless, our results implied that deltamethrin of 25 
μM had no significant effect on body size, locomotion, or growth rate of SJ4005 worms. 
However, deltamethrin showed a dose-dependent effect on the locomotion of wild-type 
C. elegans (75). It is possible that the difference in C. elegans strain may be the reason 
why no significant changes on locomotive activity by deltamethrin in the current study 
with SJ4005 worms. In fact, it has been reported that the insertion of the GFP reporter 
into the hsp-4 gene intragenetically affected the locomotive behavior of SJ4005 worms, 
as the average speed of SJ4005 worms is slower than that of the N2 worm used in the 
previous study (6, 85). 
Overall, the current results suggest that deltamethrin induces ER stress response 
in C. elegans and increases accumulation as well as the proteotoxicity of polyglutamine 
aggregates. Further studies are necessary, however, to determine how deltamethrin 
induces ER stress response and increases protein misfolding by examining potential 






Currently, there are limited reports on the role of deltamethrin in ER stress and ER stress-
related diseases. In the present study, we discovered that deltamethrin can induce ER 
stress, increase accumulation of unfolded and misfolded proteins, and increase the 
proteotoxicity of polyglutamine aggregation in C. elegans. However, the exact 
mechanism how deltamethrin induces ER stress and disturbs protein homeostasis is not 
known. Since deltamethrin alters the activity of both voltage-gated sodium and calcium 
channel, deltamethrin may disturb ER protein homeostasis and triggers UPRER through 
increasing the calcium concentration (5, 77). In order to test this hypothesis in C. elegans, 
the expression level of ER Calcium transporter SERCA (Sarco/Endoplasmic Reticulum 
Calcium ATPase) may be evaluated to determine if deltamethrin disturbs the calcium 
homeostasis in the ER (86). The expression of SERCA is expected to increase if 
deltamethrin increased ER Ca2+ level (86). Alternatively, deltamethrin may also impact 
protein folding and processing through reduction of proteasomal and ribosomal activities, 
which can be examined by analyzing proteasomal activities using a fluorogenic peptide 
substrate assay and quantifying ribosomes in C. elegans (52). Moreover, the effect of 
deltamethrin has not been tested on all three branches of UPRER. The IRE-1 and the 
PERK branches are expected to be activated with deltamethrin treatment, as the 
activation of both branches was reported in the neurons (11).  
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